Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a novel transplant strategy for the long-term
benefit of patients with transfusion dependent high-risk thalassemia.